Answer to Question 1
Answer: When people with Type A personalities have a toxic core with a cynical attitude and disproportionate anger, they are considered hostile. This component of Type A increases their risk for CVD.
Answer to Question 2
Answer: Technostress is caused by a dependence on technology and a constant need to be connected via texting or online activity. The person experiencing technostress may feel obligated to respond promptly to certain or all forms of electronic communication. The negative consequences associated with iDisorders include reduced energy, sleep disorders, damaged relationships, and poor grades. Any number of stress-reduction techniques can help. Suggested answers include at least three of the following:
1. Schedule your technology usage. Set time limits, and stick to them. Remember that you don't always have to answer your phone or respond to a text or e-mail immediately. (Consider screening contacts and only responding at certain times, since there is no need to respond immediately in most situations.)
2. Limit the number of people you interact with online. Unfriend people who post or message you with annoying or offensive messages.
3. Spend more time in face-to-face interactions with people you care about than in scrolling through their Facebook posts. (You might log time spent in virtual interactions for three days and face-to-face interactions for three days, then compare the two.)
4. Be mindful of when you're the one who actually initiates electronic communication, and recognize that you can choose to postpone the conversation until you see the person face-to-face.
5. Take breaks when working with technology for long periods of time.
6. Avoid sharing intimate details online.
7. Leave devices at home or turn them off when out with family or friends or on vacation.
Geoffroy's tamarin (Saguinus geoffroyi), also known as the Panamanian, red-crested or rufous-na
Older adults may grieve intensely over the loss of a person or situation that has been a part of the
Disease-Modifying Antirheumatic Drugs (DMARDs) and Biologic Therapies
Tumor marker analysis of a patient undergoing therapy, who (1) after surgery had residual disease ...
Action of a type I topoisomerase
The Risk of Nuclear Power